varunpatho.com

Diwali Discount is available -Call 9820285316 Code name :Nisha

LFT

Liver Function Test (LFT): Complete Medical Guide – 2000 Words

A comprehensive medical article covering liver function, LFT parameters, normal values, causes of abnormal results, liver diseases, laboratory interpretation, diagnosis, prevention, and treatment.

Childhood Liver Cancer Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf

How does a clinical biochemistry analyser work?

Which Cholesterol Drug is Safest for Liver? Taking Medications Safely – Ribbon Checkup

9

1. Introduction: What is a Liver Function Test (LFT)?

The Liver Function Test, commonly called LFT, is a group of blood tests used to evaluate liver health, detect liver injury, and assess certain important functions of the liver.

The liver is one of the largest and most essential organs in the human body. It is located in the upper right portion of the abdomen, beneath the diaphragm.

The liver performs more than 500 vital functions, including metabolism, detoxification, protein synthesis, bile production, storage of nutrients, and regulation of blood glucose.

When liver cells become damaged or bile flow is disturbed, certain enzymes and substances in the bloodstream may increase or decrease.

LFT helps doctors identify these abnormalities.

However, the term Liver Function Test is somewhat misleading because several components, such as ALT and AST, primarily indicate liver cell injury rather than actual liver function.

Tests such as serum albumin and prothrombin time provide more direct information about the liver’s ability to synthesize essential proteins.

LFT is commonly recommended for patients with jaundice, hepatitis, fatty liver disease, alcohol-related liver injury, suspected drug toxicity, and chronic liver disorders.

It is also used to monitor patients receiving medications that may affect the liver.

2. Important functions of the liver

The liver is responsible for several critical physiological activities.

Metabolism of carbohydrates: The liver stores glucose as glycogen and releases glucose when required, helping maintain blood sugar levels.

Protein metabolism: The liver synthesizes albumin, clotting factors, and many other essential proteins.

Fat metabolism: The liver processes fatty acids, cholesterol, and lipoproteins.

Bile production: Bile helps digest and absorb dietary fats and fat-soluble vitamins.

Detoxification: The liver metabolizes alcohol, medicines, and many potentially harmful substances.

Storage: The liver stores glycogen, iron, copper, and certain vitamins.

Immune function: Specialized liver cells help remove microorganisms and unwanted substances from the bloodstream.

When liver disease develops, one or more of these functions may become impaired.

3. What tests are included in an LFT profile?

A standard LFT panel usually contains several biochemical parameters.

TestMain clinical significance
Total BilirubinAssesses bilirubin metabolism and excretion
Direct BilirubinHelps evaluate conjugated hyperbilirubinemia
Indirect BilirubinHelps assess unconjugated bilirubin
ALT / SGPTMarker of hepatocellular injury
AST / SGOTMarker of liver or muscle cell injury
Alkaline Phosphatase (ALP)Marker of cholestasis or bone-related activity
Gamma-Glutamyl Transferase (GGT)Supports evaluation of hepatobiliary abnormalities
Total ProteinMeasures circulating serum proteins
AlbuminHelps assess liver synthetic function
GlobulinCalculated or measured protein fraction
A/G RatioRelationship between albumin and globulin

Prothrombin time (PT) and INR are important additional tests when liver synthetic function is being assessed, especially in suspected severe liver disease.

4. Normal reference values of LFT

The following are approximate adult reference intervals. Actual values depend on the laboratory, analyzer, reagent system, age, sex, and clinical circumstances.

ParameterIllustrative adult reference range
Total Bilirubin0.2–1.2 mg/dL
Direct Bilirubin0.0–0.3 mg/dL
Indirect BilirubinApproximately 0.2–0.9 mg/dL
ALT / SGPT7–45 U/L
AST / SGOT10–40 U/L
ALP40–130 U/L
GGTApproximately 9–50 U/L
Total Protein6.0–8.3 g/dL
Albumin3.5–5.0 g/dL
Globulin2.0–3.5 g/dL
A/G RatioApproximately 1.0–2.2

These intervals are for general education only. Some professional guidelines use lower thresholds for healthy ALT levels than those reported by many laboratories.

Children, pregnant women, and older adults may have different reference intervals.

A normal LFT does not completely exclude liver disease, particularly early fibrosis or compensated cirrhosis.

5. Serum Bilirubin: Total, Direct and Indirect

Bilirubin is a yellow pigment produced mainly during the breakdown of hemoglobin from aging red blood cells.

It is transported to the liver, processed, and excreted into bile.

There are two major forms.

Indirect (unconjugated) bilirubin: This form is produced before bilirubin is processed by the liver. It is transported in the blood bound to albumin.

Direct (conjugated) bilirubin: This form has been processed by liver cells and is normally excreted through the bile ducts.

Total bilirubin represents the combined bilirubin fractions.

Causes of increased bilirubin

Increased indirect bilirubin may occur in hemolytic anemia, Gilbert syndrome, and disorders affecting bilirubin conjugation.

Increased direct bilirubin may occur in viral hepatitis, bile duct obstruction, cholestatic liver disease, and certain inherited disorders.

When bilirubin becomes sufficiently elevated, yellow discoloration of the eyes and skin may develop. This condition is called jaundice.

Patients may also experience dark urine, pale stools, itching, nausea, and abdominal discomfort, depending on the underlying cause.

6. ALT / SGPT: Alanine Aminotransferase

ALT is an enzyme found predominantly in liver cells.

When hepatocytes become damaged, ALT may leak into the bloodstream.

Therefore, ALT is considered an important biochemical marker of hepatocellular injury.

Common causes of increased ALT include viral hepatitis, metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-associated liver disease, drug-induced liver injury, and autoimmune hepatitis.

ALT may also rise temporarily following certain infections or other physiological stresses.

A mildly elevated ALT does not necessarily indicate serious liver disease, but persistent abnormalities require evaluation.

Very high ALT concentrations, sometimes exceeding 1,000 U/L, may occur in acute viral hepatitis, severe drug-induced liver injury, or ischemic liver injury.

The degree of ALT elevation does not always correlate with the severity of liver dysfunction.

7. AST / SGOT: Aspartate Aminotransferase

AST is present in the liver, heart, skeletal muscles, kidneys, and other tissues.

Consequently, increased AST is not always caused by liver disease.

AST may rise following muscle injury, strenuous exercise, rhabdomyolysis, or hepatocellular damage.

Doctors often interpret AST together with ALT.

AST/ALT ratio

The AST/ALT ratio can provide useful clinical information.

In many forms of hepatocellular injury, ALT is higher than AST.

An AST/ALT ratio above 2 may support alcohol-associated liver injury in an appropriate clinical context, although it is not diagnostic.

An increased ratio may also occur in advanced liver fibrosis or cirrhosis.

The ratio should never be used independently to establish the cause of liver disease.

8. Alkaline Phosphatase (ALP)

ALP is an enzyme associated with bile ducts, bone, intestine, and placenta.

Increased ALP may indicate impaired bile flow, known as cholestasis.

Possible causes include gallstones obstructing the bile duct, bile duct strictures, primary biliary cholangitis, primary sclerosing cholangitis, and certain liver tumors.

However, ALP may also increase in bone disorders, during childhood growth, and during pregnancy.

Therefore, an isolated increase in ALP does not automatically indicate liver disease.

Doctors may request GGT or other investigations to help determine whether the increased ALP originates from the liver.

9. Gamma-Glutamyl Transferase (GGT)

GGT is an enzyme associated with the liver and biliary system.

It is useful in evaluating suspected hepatobiliary disease, particularly when ALP is elevated.

Increased GGT may occur in cholestasis, alcohol-associated liver disease, fatty liver disease, and with certain medications.

However, GGT is sensitive but relatively nonspecific.

A high GGT does not prove excessive alcohol consumption, and a normal GGT does not exclude liver disease.

GGT should be interpreted together with ALP, ALT, AST, bilirubin, and clinical findings.

10. Serum Total Protein, Albumin and Globulin

The liver synthesizes albumin and many other important proteins.

Albumin helps maintain plasma oncotic pressure and transports hormones, medications, and other substances.

Low serum albumin may occur in advanced chronic liver disease, but it may also result from kidney disease, malnutrition, inflammation, or protein-losing gastrointestinal disorders.

Globulins include various proteins involved in immunity and other physiological processes.

Increased globulin concentrations may occur in chronic inflammation, infections, autoimmune conditions, and certain hematological diseases.

The albumin-to-globulin ratio, or A/G ratio, is calculated from these protein fractions.

A reduced A/G ratio may be observed in chronic liver disease, but it is not specific enough to diagnose liver disorders independently.

11. Prothrombin Time (PT) and INR

Prothrombin time evaluates the blood-clotting process and provides important information about the production of clotting factors.

Most clotting factors are synthesized by the liver.

When severe liver dysfunction develops, production of these proteins may decrease, leading to prolonged PT and increased INR.

However, vitamin K deficiency, anticoagulant medications, and other conditions may also affect these measurements.

PT/INR is particularly important in suspected acute liver failure.

In patients with chronic liver disease, INR contributes to certain prognostic scores, including MELD.

An increased INR in liver disease does not directly measure the patient’s overall bleeding risk because both procoagulant and anticoagulant factors may be altered.

12. Common diseases detected or investigated through LFT

Discover EECP | The Natural Bypass | Docs Out Side The Box

Fatty Liver Disease (MASLD)

Excess fat accumulates within liver cells. It is commonly associated with obesity, insulin resistance, type 2 diabetes, and metabolic abnormalities. ALT may be mildly elevated, but LFT can also be normal.

Hepatitis. inflammation of the liver tissue

Viral Hepatitis

Hepatitis A, B, C, and E can cause liver inflammation. ALT and AST may increase significantly. Specific viral markers are required to identify the infection.

Diagnosis and Treatment of Alcohol-Associated Liver Disease | Surgery | JN Learning | AMA Ed Hub

Liver Cirrhosis

Cirrhosis is advanced liver scarring. Albumin may decrease, bilirubin may increase, and INR may become prolonged. Liver enzymes can remain normal or only mildly elevated despite advanced disease.

Intern Ultrasound of the Month: A Quick Bedside Rule Out of Cholelithiasis/Cholecystitis — University Hospitals Emergency Medicine Residency

Biliary Obstruction

Gallstones or other obstructions may prevent normal bile drainage. ALP, GGT, and direct bilirubin frequently increase.

13. LFT in diabetes and metabolic disorders

Liver health is particularly important in patients with type 2 diabetes.

Diabetes, insulin resistance, obesity, and abnormal cholesterol levels are closely associated with MASLD, previously commonly called non-alcoholic fatty liver disease (NAFLD).

Some patients develop metabolic dysfunction-associated steatohepatitis (MASH), which involves liver inflammation and injury.

Over time, MASH may progress to fibrosis and cirrhosis.

However, normal ALT and AST do not exclude significant liver fibrosis.

Patients with diabetes and suspected MASLD may benefit from fibrosis risk assessment using tools such as FIB-4, followed by elastography when indicated.

FIB-4 uses age, AST, ALT, and platelet count. It has important limitations, particularly in older adults, and age-adjusted interpretation is necessary.

Regular diabetes management, weight optimization, physical activity, and appropriate treatment of metabolic risk factors are important for liver health.

14. LFT during pregnancy

Pregnancy produces several physiological changes that influence laboratory test results.

Serum albumin generally decreases because of plasma volume expansion.

ALP may increase because the placenta produces additional alkaline phosphatase.

However, ALT, AST, and GGT do not normally rise substantially solely because of pregnancy.

Abnormal liver tests during pregnancy may require evaluation for pregnancy-specific conditions such as intrahepatic cholestasis of pregnancy, preeclampsia, HELLP syndrome, and acute fatty liver of pregnancy.

Other liver diseases, including viral hepatitis and gallstone disease, may also occur.

Pregnant patients with jaundice, severe itching, abdominal pain, headache, high blood pressure, or abnormal liver tests should receive prompt medical assessment.

15. LFT in children and elderly patients

LFT interpretation differs across age groups.

In newborns, bilirubin metabolism is immature, and physiological jaundice may occur. Nevertheless, severe or prolonged jaundice requires careful evaluation.

Children and adolescents may have higher ALP levels because of active bone growth.

In elderly patients, chronic illnesses, multiple medications, reduced nutritional intake, and age-related physiological changes can affect LFT results.

Therefore, age-appropriate reference intervals and clinical interpretation are essential.

16. How is an LFT blood sample collected?

LFT is generally performed using a venous blood sample.

A trained phlebotomist collects blood into an appropriate serum or plasma collection tube according to laboratory requirements.

The specimen is processed, centrifuged when necessary, and analyzed using automated clinical chemistry instruments.

Modern laboratories commonly employ spectrophotometric and enzymatic methods for measuring liver enzymes, bilirubin, proteins, and related parameters.

Important laboratory precautions

Proper patient identification, correct specimen labeling, suitable collection tubes, and timely sample processing are essential.

Hemolysis can interfere with several biochemical measurements, particularly AST, and may affect other analytes depending on the method.

Marked lipemia and icterus can also interfere with certain analytical procedures.

Laboratories should use validated methods, internal quality control, external quality assessment, and appropriate calibration procedures.

For bilirubin testing, unnecessary exposure to strong light should be avoided because bilirubin is light-sensitive.

17. Is fasting required for LFT?

Fasting is generally not required for a routine LFT panel.

However, the doctor or laboratory may recommend fasting when LFT is combined with other investigations, such as fasting blood glucose or certain metabolic assessments.

Patients should inform the laboratory about their medications, supplements, alcohol consumption, and recent strenuous exercise when clinically relevant.

Prescribed medicines should not be stopped without medical advice.

18. How to interpret abnormal LFT patterns

Doctors commonly classify abnormal liver biochemistry into three broad patterns.

PatternMain abnormalitiesPossible causes
HepatocellularALT and AST predominantly elevatedViral hepatitis, drug injury, MASLD
CholestaticALP predominantly elevated, often with GGTBile duct obstruction, cholestatic diseases
MixedBoth aminotransferases and ALP elevatedDrug injury, hepatitis with cholestasis, other disorders

The R ratio can help classify the pattern of liver injury:

\[ R=\frac{ALT/ALT\ ULN}{ALP/ALP\ ULN} \]

Here, ULN means the upper limit of normal for the respective laboratory assay.

An R ratio of 5 or greater suggests a hepatocellular pattern, 2 or less suggests a cholestatic pattern, and between 2 and 5 suggests a mixed pattern.

This classification is especially useful in evaluating suspected drug-induced liver injury. It does not identify the underlying diagnosis by itself.

19. How to maintain a healthy liver

Healthy lifestyle practices can help prevent several common liver disorders.

  1. Maintain a healthy body weight and waist circumference.
  2. Control diabetes, blood pressure, and cholesterol.
  3. Follow a balanced diet containing vegetables, fruits, whole grains, and appropriate protein.
  4. Exercise regularly according to individual fitness and medical conditions.
  5. Avoid alcohol or seek medical advice about stopping alcohol use.
  6. Avoid unnecessary medications and unregulated herbal supplements.
  7. Receive hepatitis A and B vaccination when recommended.
  8. Practice safe injection procedures and avoid sharing needles.
  9. Use safe drinking water and hygienic food practices.
  10. Obtain appropriate medical evaluation when liver tests remain abnormal.

There is no scientifically established liver-detox drink that replaces normal liver function or treats serious liver disease.

Treatment depends on the underlying cause.

20. When should a patient consult a doctor?

Mildly abnormal LFT results are common and do not always indicate serious disease.

However, persistent abnormalities should not be ignored.

Medical consultation is particularly important when patients experience yellow eyes or skin, dark urine, pale stools, persistent itching, unexplained fatigue, abdominal swelling, or unexplained weight loss.

Urgent medical attention is required for jaundice accompanied by confusion, unusual bleeding, severe abdominal pain, high fever, or marked deterioration in general condition.

Patients taking potentially hepatotoxic medications should follow their clinician’s recommended monitoring schedule.

21. Frequently asked questions about LFT

Q1. Can LFT detect fatty liver?

LFT may show abnormal liver enzymes in fatty liver disease, but it cannot reliably confirm or exclude fatty liver. Ultrasound or other imaging may be required.

Q2. Can LFT diagnose hepatitis B or hepatitis C?

No. LFT may identify liver injury, but specific tests such as HBsAg and anti-HCV, followed by appropriate confirmatory investigations, are necessary.

Q3. Can LFT detect liver cancer?

LFT may be abnormal in liver cancer, but it is not a screening or diagnostic test for liver cancer. Imaging and other investigations are required.

Q4. Does a normal LFT mean the liver is completely healthy?

No. Some patients with advanced fibrosis or compensated cirrhosis may have relatively normal liver enzyme levels.

Q5. How frequently should LFT be performed?

The frequency depends on medical history, medication use, underlying liver disease, and the doctor’s recommendation. Routine repeated testing is not necessary for every healthy person.

Q6. Is increased SGPT always dangerous?

Not necessarily. Mild elevations can have several causes, but persistent, marked, or symptomatic elevations require appropriate medical evaluation.

Q7. Can liver damage be reversed?

Some liver conditions, including early fatty liver and certain forms of inflammation, may improve when the underlying cause is treated. Advanced cirrhosis may be irreversible, although treatment can sometimes prevent progression.

22. Conclusion

The Liver Function Test is an essential investigation in modern clinical medicine and laboratory diagnostics.

It provides valuable information about liver cell injury, bilirubin metabolism, bile flow, and certain aspects of liver synthetic function.

The most commonly measured parameters include bilirubin, ALT, AST, ALP, GGT, total protein, albumin, and globulin.

However, abnormal LFT results should never be interpreted independently of clinical findings.

A mildly elevated liver enzyme does not necessarily indicate severe liver disease, while normal liver enzymes do not always exclude significant pathology.

Early recognition of liver abnormalities, appropriate medical evaluation, management of diabetes and metabolic risk factors, vaccination against preventable viral hepatitis, and healthy lifestyle practices can help reduce the burden of liver disease.

The most important principle is that LFT is a valuable screening and monitoring tool, but accurate diagnosis requires correlation with medical history, physical examination, imaging, and other laboratory investigations.

References and further reading

  1. MedlinePlus — Liver Function Tests
  2. NIDDK — Liver Disease Information
  3. American Association for the Study of Liver Diseases — Clinical Guidelines
  4. Mayo Clinic — Liver Function Tests
  5. American College of Gastroenterology — MASLD and Liver Fibrosis Assessment

Medical disclaimer: This article is for educational and health-awareness purposes. Reference intervals and clinical decisions should follow validated laboratory methods and professional medical guidance.

This article can be used as educational website content for Varun Pathology Lab. For publication, a suitable SEO title is “Liver Function Test (LFT): Normal Range, SGPT, SGOT, Bilirubin, Causes and Interpretation.”

Shopping Cart
Scroll to Top